Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: AHF (High Purity) Dried Factor VIII Fraction
Active Ingredient: Factor VIII, human 250IU
Dosage Form: Powder for injection
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Broadmeadows, Victoria, Australia
Note: This consent is valid for two years from 25 February 2005.
Dated this 9th day of December 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8336